NCT06574113 Validation of Cuffless Blood Pressure Measurements Using the Perin Health Patch
| NCT ID | NCT06574113 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Perin Health Devices |
| Condition | Blood Pressure |
| Study Type | OBSERVATIONAL |
| Enrollment | 85 participants |
| Start Date | 2024-08-15 |
| Primary Completion | 2024-10-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 85 participants in total. It began in 2024-08-15 with a primary completion date of 2024-10-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to validate a proprietary cuffless blood pressure algorithm using measurements from a multi-modal chest-worn medical device, the Perin Health Patch (PHP).
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years or older, * Willing and able to provide informed consent, * Able to comply with study procedure. Exclusion Criteria: * Any member defined under 'Special Population' in the AAMI standards (Pregnant, children, arm circumference \> 42 cm), * Patient with a pacemaker, * History of reactions to medical adhesives, * Inability to comply with the study procedure, * Non-English Speaker.
Contact & Investigator
Ian M McLane, Ph.D.
PRINCIPAL INVESTIGATOR
Perin Health Devices
Frequently Asked Questions
Who can join the NCT06574113 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Blood Pressure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06574113 currently recruiting?
Yes, NCT06574113 is actively recruiting participants. Contact the research team at imclane@phasemargin.com for enrollment information.
Where is the NCT06574113 trial being conducted?
This trial is being conducted at Woodland Hills, United States.
Who is sponsoring the NCT06574113 clinical trial?
NCT06574113 is sponsored by Perin Health Devices. The principal investigator is Ian M McLane, Ph.D. at Perin Health Devices. The trial plans to enroll 85 participants.